Understanding common peptide mass shift caused by side reactions is essential for accurate LC-MS data interpretation in peptide synthesis and analysis.
| Nominal Mass Shift [Da] | Affected Residue(s) | Modification |
|---|---|---|
| – | All | Dipeptide Masses |
| – | N-term | Diketopiperazine (DKP) Formation |
| -36 | D, E, S, T, N, Q | Dehydration (2 x H2O) |
| -34 | C | Cysteine beta-elimination (Dehydroalanine) |
| -30 | M | Homoserine lactone artifact (result of CNBr chemical cleavage at Met) |
| -18 | D, E, S, T, N, Q | Dehydration (1 x H2O) |
| -18 | D | Aspartimide (succinimide) formation from Asp |
| -18 | E | Pyroglutamate or Glutarimide Formation on Glu |
| -17 | N | Aspartimide (succinimide) formation from Asn |
| -17 | Q | Pyroglutamate or Glutarimide Formation on Gln |
| -2 | C | Disulfide Bond Formation; Cysteine Oxidation |
| -2 | C | Cysteine Sulfenamide Formation |
| -1 | C-term, D, E | Amidation of Carboxylic Group |
| 0 | All | Peptide Modifications With Identical Masses |
| 1 | C-term | C-Terminal Amide Group Hydrolysis |
| 1 | N, Q | Hydrolysis of Asn or Gln Side Chains (Aspartimide formation) |
| 1 | R | Deimination of Arginine side chain to Citrulline |
| 2 | C | Disulfide Bond (Cystine) Reduction |
| 2 | W | Reduction of Trp Side Chain Groupe (Indole) |
| 4 | W | Oxidation of Trp to Kynurenine |
| 12 | N-term, K, C, W | Formaldehyde adduct (plastic leachable or solvent impurity, usually on Cys, Trp, or N-terminus) |
| 14 | C-term, D, E | Methyl Esterification of the Carboxyl Groups |
| 14 | N-term, K | N-Methylation |
| 14 | C | Thiosulfinate Formation |
| 16 | M | Methionine Oxidation |
| 16 | C | Oxidation of Cysteine to Cysteine Sulfenic Acid |
| 16 | H | Oxidation of Histidine to 2-O-Histidine |
| 16 | W | Oxidation of Tryptophan to Oxindolylalanine (Trp to Oia) |
| 16 | C | Thiosulfinate Formation |
| 22 | All | Sodium cation adduct (replacement of one proton) |
| 28 | N-term, K | N,N-Dimethylation |
| 28 | N-term | N-terminal formylation (frequently caused by degraded DMF solvent) |
| 30 | C | Thiosulfonate Formation |
| 32 | C | Trisulfide Bond Formation |
| 32 | M | Methionine Oxidation |
| 32 | C | Cysteine Sulfinic Acid Formation |
| 32 | C | Thiosulfonate Formation |
| 32 | W | Oxidation of Tryptophan to N-Formylkynurenine |
| 34 | Y, W | Monochlorination artifact (e.g., Tyrosine modification from bleach or scavenger traces) |
| 38 | All | Potassium cation adduct (replacement of one proton) |
| 40 | S, T | Serine or Threonine Pseudoproline (Psi-Me,MePro) |
| 42 | N-term, K | Acetylation |
| 43 | N-term, K | Carbamylation of primary amines (common artifact when using urea buffers) |
| 44 | W | Incomplete Tryptophan Boc Group Removal |
| 48 | C | Cysteine Sulfonic Acid Formation |
| 51 | C | Fmoc-Cys(Acm)-OH or Fmoc-Cys(Trt)-OH Side Reaction with Piperidine |
| 56 | C, M, W, Y | Peptide tert-Butylation (monoalkylated) |
| 57 | G | Glycine Mass Shift |
| 57 | M | Methionine Tert-Butylation (monoalkylated) |
| 65 | C | Cys Side Reaction with 4-Methylpiperidine |
| 67 | D | Piperidide Peptide from Asp |
| 68 | N | Piperidide Peptide from Asn |
| 71 | A | Alanine Mass Shift |
| 71 | C | Acetamidomethyl (Acm) protecting group |
| 78 | Y, W | Monobromination artifact (e.g., on Tyrosine) |
| 80 | R, W, Y | Sulfonation (SO3H addition) |
| 80 | S, T, Y | Phosphorylation (addition of phosphate to Ser, Thr, or Tyr) |
| 92 | C | Cysteine-EDT Adduct Formation |
| 96 | N-term, K, S, T, Y | Trifluoroacetylation of -NH2 od -OH groups |
| 97 | P | Proline Mass Shift |
| 98 | N-term, K | Guanidinium Formation on Amino Group |
| 99 | V | Valine Mass Shift |
| 100 | N-term, K, W | tert-Butyloxycarbonyl (Boc) |
| 101 | T | Threonine Miss Coupling |
| 103 | C | Cysteine Mass Shift |
| 106 | C, W, C-term | Cys, Trp, or C-Terminys Alkylation by Wang Resin Linker: 4-Hydroxylbenzylation |
| 112 | C, M, W, Y | Peptide tert-Butylation (dialkylated) |
| 113 | I | Isoleucine Mass Shift |
| 113 | L | Leucine Mass Shift |
| 114 | N | Asparagine Mass Shift |
| 114 | M | Methionine Tert-Butylation (dialkylated) |
| 115 | D | Aspartate Mass Shift |
| 117 | M | Methionine Alkylation dy DODT |
| 128 | Q | Glutamine Mass Shift |
| 128 | K | Lysine Mass Shift |
| 129 | E | Glutamate Mass Shift |
| 131 | M | Methionine Mass Shift |
| 134 | N-term, K | Benzyloxycarbonyl (Cbz or Z) protecting group |
| 137 | H | Histidine Mass Shift |
| 147 | F | Phenylalanine Mass Shift |
| 148 | C | Cysteine-EDT-tBu Adduct Formation |
| 154 | R, H | Tosyl (Tos) protecting group |
| 156 | R | Arginine Mass Shift |
| 160 | R, W, Y | Disulfonation (2xSO3H) |
| 163 | W | Rink amide MBHA linker Trp Alkylation |
| 163 | Y | Tyrosine Mass Shift |
| 166 | N-term, K, H | 2,4-Dinitrophenyl (Dnp) modification |
| 172 | W | Trp-EDT-TFA Cyclic Adduct |
| 178 | N-term, K, C, W | Dibenzofulvene Peptide Alkylation |
| 186 | W | Tryptophan Mass Shift |
| 202 | C, W, C-term | Trp, Cys, or C-Terminus Alkylation by Wang Resin Linker: 4-Trifluoroacetyoxybenzylation |
| 212 | R | 4-Methoxy-2,3,6-trimethylbenzenesulfonyl (Mtr) |
| 212 | W | Trp 4-Hydroxylbenzyl Dialkylation by Wang Resin Linker |
| 222 | N-term, K | Fmoc group |
| 226 | N-term, K | Biotinylation tag (via amide bond) |
| 233 | N-term, K | Dansyl (Dns) fluorescent tag |
| 242 | C, H, N, Q | Trtylation |
| 252 | R | Pbf Derivative |
| 265 | W | Tryptophan-Pal linker Alkylation |
| 266 | R | Pmc Derivative |
| 274 | C | Cysteine Sulfinic Acid + Trt Group Derivative |
| 308 | W | Trp 4-Hydroxylbenzyl and 4-Trifluoroacetyloxybenzyl Dialkylation (Wang Resin Linker) |
| 359 | N-term, K, C | Fluorescein label addition |
| 404 | W | Trp 4-Trifluoroacetyloxybenzyl Dialkylation (Wang Resin Linker) |
Optimize Your Synthesis Strategy with Peptalyzer™
While this peptide mass shift table helps you diagnose what happened in the flask, Peptalyzer™ helps you prevent it. Run a Chemical Stability Audit on your target sequence to identify oxidation-prone residues, aspartimide hotspots, and sequence-dependent risks before you even weigh out your resin.
Interpreting Peptide Mass Shift Patterns from Common Side Reactions
Unexpected peptide mass shifts (ΔM) frequently result from well-characterized side reactions occurring during Fmoc-SPPS, TFA cleavage, or purification. Identifying these precise mass deviations is critical for diagnosing synthetic bottlenecks—whether it’s an incomplete protecting group removal (e.g., +252 Da Pbf adducts), a scavenger artifact, or an unintended oxidation.
This mass shift table provides a rapid diagnostic reference for common synthetic modifications. Use the Affected Residue(s) column to cross-reference unexpected peaks against your target sequence. Where applicable, click on highlighted modifications for detailed mechanistic explanations and prevention strategies.
Peptide Mass Shift — FAQ
True covalent modifications (like unremoved protecting groups or oxidations) are distinct chemical entities. They will typically have a different HPLC retention time than your target peptide. Conversely, LC-MS artifacts—such as metal adducts (Sodium +22 Da, Potassium +38 Da) or in-source fragmentation—occur during the ionization process inside the mass spectrometer. If the shifted mass perfectly co-elutes with your main product peak, it is highly likely to be an ionization artifact rather than a synthesis failure.
If a mass shift does not match a single entry, it is frequently a combination of multiple side reactions or adducts. For instance, a +38 Da shift might not be a single event; it could be an oxidation (+16 Da) combined with a Sodium adduct (+22 Da). When troubleshooting an unknown mass, always subtract common ionization adducts first, then look for combinations of expected protecting groups based on your sequence.
Chemical artifacts are highly residue-specific. You can drastically reduce your troubleshooting time by cross-referencing your observed mass shift with the Affected Residue(s) column. For example, if you see a +16 Da shift but your sequence lacks Methionine, Cysteine, Tryptophan, or Histidine, you can safely rule out standard oxidation and start investigating alternative causes, such as a synthesis deletion or a solvent contaminant.
Chemical artifacts are highly residue-specific. You can drastically reduce your troubleshooting time by cross-referencing your observed mass shift with the Affected Residue(s) column. For example, if you see a +16 Da shift but your sequence lacks Methionine, Cysteine, Tryptophan, or Histidine, you can safely rule out standard oxidation and start investigating alternative causes, such as a synthesis deletion or a solvent contaminant.
Yes. While this mass shift table is designed for post-synthesis LC-MS troubleshooting, you can take a proactive approach using the Chemical Stability Audit in Peptalyzer™. By inputting your target sequence before beginning your synthesis, Peptalyzer automatically scans for high-risk sequence motifs (such as Asp-Gly for aspartimide formation, or N-terminal Gln for pyroglutamate). This allows you to anticipate potential mass shifts and adjust your synthetic strategy—such as utilizing Dmb-protected dipeptides—before wasting reagents.
The mass shift table is an exhaustive diagnostic reference that includes unpredictable, environmentally dependent artifacts—such as metal adducts (+22 Da Na+), solvent contaminants (formylation), or incomplete scavenger trapping. In contrast, the Peptalyzer™ Chemical Stability Audit focuses purely on sequence-dependent chemical risks (like oxidation-prone Met/Trp/Cys residues or specific degradation motifs). Peptalyzer predicts what is structurally likely to happen based on your sequence, while this table helps you diagnose what actually happened in the flask.